Production system QbCon®

The paradigm change from batch production to continuous manufacture requires a new approach for the production processes used, as well as for the required automation technology. Comprehensive initiatives for quality increase – mainly driven by the FDA – strongly focuses on continuous manufacturing for manufacture of solid drugs. The ability to monitor a production process more closely using PAT, and to consistently produce high-quality products as a result, is the central aspect of this initiative. - Higher patient safety - Lower costs - Better process understanding - Optimised process control As the most innovative technology company for machines and processes for the pharmaceutical solids production, L.B. Bohle supplies comprehensive solutions for continuous manufacturing with a high development speed. Modular design: Direct compression, wet granulation, and dry granulation The QbCon® continuous manufacturing systems allows for production of pharmaceutical solids from powder to the coated tablet with a throughput from 5 to 25 kg/h. QbCon® stands out with its modular design that ensures maximum flexibility and efficiency for the customer. QbCon® enables three production processes: Continuous direct compression Continuous wet granulation Continuous dry granulation